CompoAtlas

Lipofit Extreme 2.0 Fat Burner

Finding published by the FDA

Finding published by the FDA

Finding date: 4 June 2026.

Undeclared fluoxetine and 2,4-dinitrophenol (DNP)

FDA finding date
4 June 2026
Company
Ana Salazar Modela Tu Cuerpo Inc.
Subject published by the FDA
Undeclared fluoxetine and 2,4-dinitrophenol (DNP)
Published action
Public Notification
Programme
Drugs
Published follow-up
Recall

This official finding is dated and does not necessarily describe the product currently sold under this name. It does not constitute an analysis of its complete composition.

The subject and action are reproduced as published by the FDA, without generalisation to all batches or other products from the company.

Substances named in the FDA finding

Published namePublished text and quantityRecognised ingredientRole or context
fluoxetineUndeclared fluoxetine and 2,4-dinitrophenol (DNP)Not recognisedSubstance named by the FDA
2,4-dinitrophenol (DNP)Undeclared fluoxetine and 2,4-dinitrophenol (DNP)Not recognisedSubstance named by the FDA

Substances named in the FDA finding do not constitute a complete composition. No quantity or dose is inferred.

Sites cited by the FDA

anasalazar.us.com

Official source

View the FDA finding

Related FDA document

Food and Drug Administration, Health Fraud Product Database. Dated official findings.

Domaine public (politique du site FDA)

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Lipofit Extreme 2.0 Fat Burner”, https://compoatlas.com/en/supplements/us-fraud/f3b392a337080744cd6b597cc02a2f9fa4f1d05b8929c7b4f5179c7b6f56e8e4-lipofit-extreme-2-0-fat-burner, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line